[1]董佳鑫,王海艳,NOUTCHIE VINYE Nana(喀麦隆),等.幽门螺杆菌感染致表皮生长因子及其受体表达上调与胃癌发生及发展机制关系研究进展[J].陕西医学杂志,2024,(6):853-857.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.028]
　DONG Jiaxin,WANG Haiyan,NOUTCHIE VINYE Nana,et al.Research progress on relationship between up-regulation of EGF/EGFR expression caused by Helicobacter pylori and mechanism of gastric cancer development[J].,2024,(6):853-857.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.028]
点击复制

幽门螺杆菌感染致表皮生长因子及其受体表达上调与胃癌发生及发展机制关系研究进展
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年6期
页码:
853-857
栏目:
综 述
出版日期:
2024-06-05

文章信息/Info

Title:
Research progress on relationship between up-regulation of EGF/EGFR expression caused by Helicobacter pylori and mechanism of gastric cancer development
作者:
董佳鑫1; 2; 王海艳3; NOUTCHIE VINYE Nana1(喀麦隆); 周彬健1; 2; 吴庆田1; 2
(1.佳木斯大学基础医学院,黑龙江 佳木斯 154007; 2.佳木斯大学基础医学院微生态-免疫调节网络与相关疾病重点实验室,黑龙江 佳木斯 154007; 3.德州市人民医院感染性疾病科,山东 德州 253000)
Author(s):
DONG Jiaxin; WANG Haiyan; NOUTCHIE VINYE Nana; ZHOU Binjian; WU Qingtian
(Basic Medical College of Jiamusi University,Jiamusi 154007,China)
关键词:
胃癌;  幽门螺杆菌;  表皮生长因子;  表皮生长因子受体;  毒力因子;  肿瘤标志物
Keywords:
Gastric cancer;  Helicobacter pylori;  Epidermal growth factor;  Epidermal growth factor receptor;  Virulence factor;  Tumor markers
分类号:
R 735.2
DOI:
DOI:10.3969/j.issn.1000-7377.2024.06.028
文献标志码:
A
摘要:
胃癌(GC)作为常见的消化道恶性肿瘤疾病,其发病率和病死率极高。胃肠道主要致病菌幽门螺杆菌(HP)可促进胃细胞恶性转化,且与胃部细胞癌的发生、发展密切相关。HP通过定植于胃黏膜释放毒力因子上调表皮生长因子(EGF)的表达,EGF与癌变细胞外膜上表皮生长因子受体(EGFR)相互作用后,可激活下游增殖信号通路,对胃癌的发生与发展产生影响。现就HP感染所致EGF/EGFR表达上调与胃癌发生、发展机制的关系进行综述。
Abstract:
Gastric cancer(GC)is a common malignant tumor of digestive tract,with high morbidity and mortality.Helicobacter pylori(HP),the main pathogen of gastrointestinal tract,can promote the malignant transformation of gastric cells and is closely related to the occurrence and development of gastric cell carcinoma.HP releases virulence factors by colonization in gastric mucosa,and upregulates the expression of epidermal growth factor(EGF).EGF interacts with epidermal growth factor receptor(EGFR)on the outer membrane of gastric cancer cells,activating downstream tumor proliferation signal pathway,which has an impact on the occurrence and development of gastric cancer.This paper reviews the relationship between the up-regulation of EGF/EGFR expression caused by HP infection and the mechanism of gastric cancer development.

参考文献/References:

[1] FERLAY J,SOERJOMATARAM I,DIKSHIT R,et al.Cancer incidence and mortality worldwide:Sources,methods and major patterns in GLOBOCAN 2012[J].Int J Cancer,2015,136(5):e359-e386.
[2] ILIC M,ILIC I.Epidemiology of stomach cancer[J].World J Gastroenterol,2022,28(12):1187-1203.
[3] LIN C H,HSU P I,TSENG C D,et al.Application of artificial intelligence in endoscopic image analysis for the diagnosis of a gastric cancer pathogen-Helicobacter pylori infection[J].Sci Rep,2023,3(1):13380.
[4] BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[5] PADDA J,KHALID K,COOPER A C,et al.Association between Helicobacter pylori and gastric carcinoma[J].Cureus,2021,13(5):e15165.
[6] KUMAR S,METZ D C,ELLENBERG S,et al.Risk factors and incidence of gastric cancer after detection of helicobacter pylori infection:Alarge cohort study[J].Gastroenterology,2020,158(3):527-536.
[7] ITO N,TSUJIMOTO H,UENO H,et al.Helicobacter pylori-mediated immunity and signaling transduction in gastric cancer[J].Clin Med,2020,9(11):3699.
[8] LI Y,SONG Y.Diagnostic value of serum gastrin and epidermal growth factor to the gastric ulcer complicated with upper gastrointestinal hemorrhage[J].Coll Physicians Surg Pak,2020,30(12):1269-1272.
[9] LUCZAK M,FORMANORMANOWICZ D,PAWLICZAK E,et al.Chronic kidney disease-related atherosclerosis-proteomic studies of blood plasma[J].Proteome Sci,2011,9:25.
[10] MIAO R X,WAN C M,WANG Z L.The relationship of gastric microbiota and Helicobacter pylori infection in pediatrics population[J].Helicobacter,2020,25(1):e12676.
[11] SALVATORI S,MARAFINI I,LAUDISI F,et al.Helicobacter pylori and gastric cancer:Pathogenetic mechanisms[J].Int J Mol Sci,2023,24(3):2895.
[12] URIBE M L,MARROCCO I,YARDEN Y.EGFR in cancer:Signaling mechanisms,drugs,and acquired resistance[J].Cancers(Basel),2021,13(11):2748.
[13] CHENG G,MEI Y,PAN X,et al.Expression of HER2/c-erbB-2,EGFR protein in gastric carcinoma and its clinical significance[J].Open Life Sci,2019,14:119-125.
[14] BONIG T,OIBERMANN P,BATS S H,et al.Systemantic site-directed mutagenesis of the Helicobacter pylori CagA protein of the Cag type Ⅳ secretion system identifies novel functional domains[J].Sci Rep,2016,6:38101.
[15] SHIM J H,YOON J H,CHOI S S,et al.The effect of Helicobacter pylori CagA on the HER-2 copy number and expression in gastric cancer[J].Gene,2014,546(2):288-296.
[16] FANG L,GAO Y,WANG Z,et al.EGF stimulates human trophoblast cell invasion by downregulating ID3-mediated KISS1 expression[J].Cell Commun Signal,2021,19(1):101.
[17] KIM J,KIM S J,JEONG H R,et al.Inhibiting EGFR/HER-2 ameliorates neuroinflammatory responses and the early stage of tau pathology through DYRK1A[J].Front Immunol,2022,13:903309.
[18] 陈思清,周赛男,韩运宗,等.黄芪建中汤对胃溃疡大鼠血清炎症因子、胃黏膜表皮生长因子受体表达的影响[J].陕西中医,2023,44(8):1032-1036.
[19] ADASHEK J J,ARROYO-MARTINEZ Y,MENTA A K,et al.Therapeutic implications of epidermal growth factor receptor(EGFR)in the treatment of metastatic gastric/GEJ cancer[J].Front Oncol,2020,10:1312.
[20] QU Y,MA X,XUAN Z.Exploration of tuina effect and mechanism in chronic atrophic gastritis rats[J].Turk J Gastroenterol,2022,33(6):477-484.
[21] 杨建民,范玉林,刘海峰,等.萎缩性胃炎患者幽门螺杆菌根除后表皮生长因子及其受体的变化[J].胃肠病学和肝病学杂志,2004,13(4):417-419.
[22] YE J,LI J,ZHAO P.The silkworm carboxypeptidase inhibitor prevents gastric cancer cells' proliferation through the EGF/EGFR signaling pathway[J].Int J Mol Sci,2023,24(2):1078.
[23] 陈更新,李合国.养正散结汤对慢性萎缩性胃炎癌前病变胃黏膜EGF、EGFR的影响[J].中医药导报,2007,13(12):20-22.
[24] BAJ J,FORMA A,SITARZ M,et al.Helicobacter pylori virulence factors-mechanisms of bacterial pathogenicity in the gastric microenvironment[J].Cells,2020,10(1):27.
[25] YANG Y,SHU X,XIE C.An overview of autophagy in Helicobacter pylori infection and related gastric cancer[J].Front Cell Infect Microbiol,2022,12:847716.
[26] 杨露,张磊,盖中涛.幽门螺杆菌与胃肠道微生态关系的研究进展[J].中国微生态学杂志,2021,33(6):726-731.
[27] AL-FAKHRANY O M,ELEKHNAWY E.Helicobacter pylori in the post-antibiotics era:From virulence factors to new drug targets and therapeutic agents[J].Arch Microbiol,2023,205(9):301.
[28] SHANG H,CAO Z,ZHAO J,et al.Babao Dan induces gastric cancer cell apoptosis via regulating MAPK and NF-κB signaling pathways[J].J Int Med Res,2019,47(10):5106-5119.
[29] SHIRANI M,PAKZAD R,HADDADI M H,et al.The global prevalence of gastric cancer in Helicobacter pylori-infected individuals:A systematic review and meta-analysis[J].BMC Infect Dis,2023,23(1):543.
[30] SARUULJAVKHLAN B,ALFARAY R I,OYUNTSETSEG K,et al.Study of Helicobacter pylori isolated from a high-gastric-cancer-risk population:Unveiling the comprehensive analysis of virulence-associated genes including secretion systems,and genome-wide association study[J].Cancers(Basel),2023,15(18):4528.
[31] SOOND S M,ZAMYATNIN A A.Helicobacter pylori and gastric cancer:A lysosomal protease perspective[J].Gastric Cancer,2022,25(2):306-324.
[32] SANTOS J C,RIBEIRO M L.Epigenetic regulation of DNA repair machinery in Helicobacter pylori-induced gastric carcinogenesis[J].World J Gastroenterol,2015,21(30):9021-9037.
[33] HE Q,LI G,WANG X,et al.A decrease of histone deacetylase 6 expression caused by Helicobacter pylori infection is associated with oncogenic transformation in gastric cancer[J].Cell Physiol Biochem,2017,42(4):1326-1335.
[34] OUYANG Y,LIU G,XU W,et al.Helicobacter pylori induces epithelial-mesenchymal transition in gastric carcinogenesis via the AKT/GSK3β signaling pathway[J].Oncol Lett,2021,21(2):165.
[35] NOTO J M,PIAZUELO M B,ROMERO-GALLO J,et al.Targeting hypoxia-inducible factor-1 alpha suppresses Helicobacter pylori-induced gastric injury via attenuation of both cag-mediated microbial virulence and proinflammatory host responses[J].Gut Microbes,2023,15(2):2263936.
[36] DIAS A,GARCIA C,MAJEWSKI M,et al.Gastric juice prostaglandins andpeptide growth factors as potential markers of chronic atrophic gastritis,intestinal metaplasia and gastric cancer:Their potential clinical implications based on this pilot study[J].Dig Dis Sci,2011,22(4):326-335.
[37] 吴晋.替普瑞酮治疗老年HP阳性慢性萎缩性胃炎临床效果分析[J].陕西医学杂志,2021,50(6):735-737,762.
[38] SIERRA J C,ASIM M,VERRIERE T G,et al.Epidermal growth factor receptor inhibition downregulates Helicobacter pylori-induced epithelial inflammatory responses,DNA damage and gastric carcinogenesis[J].Gut,2018,67(7):1247-1260.
[39] ALGIN E,BAYKARA M,YILMAZ G,et al.Is there any relationship between Helicobacter pylori infection and human epidermal growth factor receptor 2 expression in gastric cancer[J].J Cancer Res Ther,2020,16(Supplement):s128-s132.
[40] GUNAWARDHANA N,JANG S,CHOI Y H,et al.Helicobacter pylori-induced HB-EGF upregulates gastrin expression via the EGF receptor,C-Raf,Mek1,and Erk2 in the MAPK pathway[J].Front Cell Infect Microbiol,2018,7:541.
[41] WANG H,ZHAO M,SHI F,et al.A review of signal pathway induced by virulent protein CagA of Helicobacter pylori[J].Front Cell Infect Microbiol,2023,13:1062803.

相似文献/References:

[1]侯洁心 ,郭萍△.免疫组化标志物Her2和肿瘤标志物在胃癌诊断中的价值分析*[J].陕西医学杂志,2019,(1):121.
　HOU Jiexin,GUO Ping..The value of immunohistochemical marker Her2 andtumor markers in the diagnosis of gastric cancer[J].,2019,(6):121.
[2]唐亚荣.循环热灌注化疗联合替吉奥及热疗治疗老年胃癌癌性腹水临床研究*[J].陕西医学杂志,2019,(4):435.
　TANG Yarong..Clinical effect analysis of combined therapy with tiago and hyperthermia in the treatment of malignant ascites in elderly patients with gastric cancer[J].,2019,(6):435.
[3]刘国庆,闫 龙△,高 任.1.5T磁共振扩散加权成像在胃癌淋巴结转移诊断中的应用价值*[J].陕西医学杂志,2019,(4):456.
　LIU Guoqing,YAN Long,GAO Ren..1.5T magnetic resonance diffusion weighted imaging in the diagnosis of lymph node metastasis of gastric cancer[J].,2019,(6):456.
[4]胡乃军,王海龙.胃腺癌组织中MMP11、MMP12和VEGFD的表达及临床意义[J].陕西医学杂志,2019,(5):554.
[5]米志宽,赵菊梅.抑癌基因甲基化与胃癌关系研究进展*[J].陕西医学杂志,2019,(5):679.
　MI Zhikuan,ZHAO Jumei..Research progress of relationships between tumor suppressor gene methylation and gastric cancer[J].,2019,(6):679.
[6]石颖鹏,王敏娟,李程亮.肠化生相关分子与胃癌的发生和进展研究概况[J].陕西医学杂志,2019,(7):958.
　SHI Yingpeng,WANG Minjuan,LI Chengliang,et al.Intestinal metaplasia-related molecules and the occurrence and progress of gastric cancer[J].,2019,(6):958.
[7]郭小艳,于桂萍.抗幽门螺杆菌疗法联合新辅助化疗对胃癌术后疗效及患者血清VEGF、bFGF的影响[J].陕西医学杂志,2019,(8):1010.
　GUO Xiaoyan,YU Guiping..Effect of anti-Helicobacter pylori therapy combined with neoadjuvant chemotherapy on serum VEGF and bFGF in postoperative patients with gastric cancer[J].,2019,(6):1010.
[8]柯东平,毛俊倩,郭甲民,等.SCNN1B与胃癌细胞上皮间质转化相关性实验研究*[J].陕西医学杂志,2019,(9):1115.
　KE Dongping,MAO Junqian,GUO Jiamin,et al.Research on the correlation between SCNN1B and〖JZ〗 epithelialmesenchymal transformation in gastric cancer cells[J].,2019,(6):1115.
[9]王小林,马任远,张 哲.腹腔镜手术治疗老年进展期胃癌50例临床疗效分析[J].陕西医学杂志,2019,(10):1360.
[10]刘维帅,郭晓宁,杨 洋,等.胃癌病理类型及临床预后与血清miR-133a和DKK-1相关性分析[J].陕西医学杂志,2020,49(6):751.[doi:DOI:10.3969/j.issn.10007377.2020.06.028]
　LIU Weishuai,GUO Xiaoning,YANG Yang,et al.Correlation of pathological types and clinical prognosis of gastric cancer with serum miR-133a and DKK-1[J].,2020,49(6):751.[doi:DOI:10.3969/j.issn.10007377.2020.06.028]
[11]张 琳,郭珊岚,康乐平.胃癌组织MutS同源物6、减数分裂后分离增强基因2表达与幽门螺杆菌感染及预后相关性研究[J].陕西医学杂志,2025,54(3):408.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.024]
　ZHANG Lin,GUO Shanlan,KANG Leping.Correlation of MSH6 and PMS2 expression with Helicobacter pylori infection and prognosis of gastric cancer[J].,2025,54(6):408.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.024]

备注/Memo

备注/Memo:
基金项目:国家重点专科建设项目(GJ202302); 黑龙江省自然科学基金资助项目(LH2020H003)
更新日期/Last Update: 2024-06-05